The Food and Drug Administration (FDA) is refusing to review Moderna’s experimental flu shot, the company announced Tuesday.
Already submitted and accepted for review in the European Union, Canada, and Australia, the experimental shot’s application being denied by the FDA is another sign of President Donald Trump’s administration’s impact on U.S. pharmaceutical companies.
